Avra Medical (OTC: AVMR) interview with Barry Cohen, CEO. Barry discusses the technology Avra is developing for fully autonomous robotic surgery. The company’s goal is to receive FDA approval and enter commercialization by 2020, with an initial focus on automated dermatological surgery procedures.
Frelii, Inc. (OTC: FRLI), interview with CEO Ian Jenkins discussing the company’s personalized medicine technology which uses human DNA gene sequencing and artificial intelligence (AI) to […]
MGC Pharmaceuticals, LTD. (ASX: MXC) (OTC: MGCLF) CEO Interview with Roby Zomer, discussing the company’s vertically integrated “Seed-to Pharmacy” strategy, and product pipeline. The company has three […]
Ventripoint Diagnostics (TSX. V: VPT) (OTC: VPTDF) interview with Dr. George Adams, CEO, discussing the company’s innovative AI-driven medical imaging technology addressing the cardio and cancer markets. […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
